S. 252 · 115th Congress
Medicare Drug Savings Act of 2017
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
NelsonSponsor15 cosponsors · 13 D, 2 I
D
Brown
TB
D
Baldwin
RB
D
Blumenthal
RD
D
Durbin
AF
D
Franken
MH
D
Hirono
AK
D
Klobuchar
AK
I
King
PL
D
Leahy
JR
D
Reed
BS
I
Sanders
DS
D
Stabenow
TU
D
Udall
SW
D
Whitehouse
JS
D
Shaheen14 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for prescription drugs dispensed to eligible low-income individuals under the Medicare prescription drug benefit or a Medicare Advantage (MA) prescription drug plan (PDP).
What it does: CRS summary · Introduced in Senate · Feb 1, 2017
Medicare Drug Savings Act of 2017
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for prescription drugs dispensed to eligible low-income individuals under the Medicare prescription drug benefit or a Medicare Advantage (MA) prescription drug plan (PDP).
Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report, both to drug manufacturers and to the CMS, specified information related to the determination and payment of such rebates.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Medicare Drug Savings Act of 2017
Latest action (Feb 1, 2017): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: Feb 1, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.